Darren S. Cline

Insider Reports History

Location
Burnaby
Signature
/s/ Nathaniel Adams, Attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Darren S. Cline:

Company Role Class Num Shares Value Price $ Report Date Ownership
PLIANT THERAPEUTICS, INC. Director Common Stock (Right to Buy) 30,000 $55,669 $2.08 05 Jun 2025 Direct
Pyxis Oncology, Inc. Director Stock Option (Right to Buy) 36,979 $36,239 $0.9800 31 Mar 2025 Direct
Xenon Pharmaceuticals Inc. Chief Commercial Officer Share Option (Right to Buy) 40,000 09 Jan 2026 Direct
Xenon Pharmaceuticals Inc. Chief Commercial Officer Restricted Share Units 20,000 09 Jan 2026 Direct
IMPEL PHARMACEUTICALS INC Director Stock Option (right to buy) 13,222 16 Jun 2023 Direct
GW PHARMACEUTICALS PLC U.S. Chief Commercial Officer Ordinary Shares 0 05 May 2021 Direct
GW PHARMACEUTICALS PLC U.S. Chief Commercial Officer Share Options 0 05 May 2021 Direct
Xenon Pharmaceuticals Inc. Chief Commercial Officer No securities are beneficially owned. 0 23 Jun 2025 Direct

Insider Reports Filed by Darren S. Cline

Symbol Company Period Transactions Value $ Form Type Role Filing Time
XENE Xenon Pharmaceuticals Inc. 09 Jan 2026 2 $0 4 Chief Commercial Officer 09 Jan 2026, 18:53
XENE Xenon Pharmaceuticals Inc. 23 Jun 2025 1 $0 4 Chief Commercial Officer 24 Jun 2025, 21:35
XENE Xenon Pharmaceuticals Inc. 23 Jun 2025 0 $0 3 Chief Commercial Officer 24 Jun 2025, 21:33
PLRX PLIANT THERAPEUTICS, INC. 05 Jun 2025 1 $0 4 Director 09 Jun 2025, 20:43
PYXS Pyxis Oncology, Inc. 31 Mar 2025 1 +$36,239 4 Director 02 Apr 2025, 09:01
PLRX PLIANT THERAPEUTICS, INC. 13 Jun 2024 1 $0 4 Director 17 Jun 2024, 20:15
PYXS Pyxis Oncology, Inc. 26 Mar 2024 1 $0 4 Director 28 Mar 2024, 16:33
/report/000120919123038606-cline-darren-s-2023-06-16 IMPEL PHARMACEUTICALS INC 16 Jun 2023 1 $0 4 Director 20 Jun 2023, 18:41
PLRX PLIANT THERAPEUTICS, INC. 07 Jun 2023 1 $0 4 Director 08 Jun 2023, 17:09
/report/000120919123024348-cline-darren-s-2023-04-12 IMPEL PHARMACEUTICALS INC 12 Apr 2023 1 $0 4 Director 14 Apr 2023, 16:58
/report/000120919123024248-cline-darren-s-2023-04-12 IMPEL PHARMACEUTICALS INC 12 Apr 2023 0 $0 3 Director 13 Apr 2023, 18:10
PYXS Pyxis Oncology, Inc. 24 Mar 2023 1 $0 4 Director 28 Mar 2023, 16:41
PLRX PLIANT THERAPEUTICS, INC. 06 Mar 2023 1 $0 4 Director 08 Mar 2023, 15:36
PLRX PLIANT THERAPEUTICS, INC. 06 Mar 2023 0 $0 3 Director 08 Mar 2023, 15:33
PYXS Pyxis Oncology, Inc. 31 Mar 2022 1 $0 4 Director 04 Apr 2022, 16:15
PYXS Pyxis Oncology, Inc. 08 Dec 2021 1 +$93,885 4 Director 09 Dec 2021, 15:18
PYXS Pyxis Oncology, Inc. 07 Oct 2021 1 $0 4 Director 12 Oct 2021, 19:47
PYXS Pyxis Oncology, Inc. 07 Oct 2021 0 $0 3 Director 07 Oct 2021, 21:10
/report/000089924321018670-cline-darren-s-2021-05-05 GW PHARMACEUTICALS PLC 05 May 2021 8 $0 4 U.S. Chief Commercial Officer 07 May 2021, 16:21